Gewinn- und Verlustrechnung von Medifast, Inc.

Baltimore, MD, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Weight comes back after weight loss when the conditions that drove it were never addressed during the weight loss phase. Trilivy™, a science-backed, coach-guided comprehensive metabolic health system, points to five factors research identifies as drivers of weight regain, rooted in body composition and habit infrastructure.

Baltimore, MD, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The signs of poor metabolic health can be difficult to analyze without a clinical framework. Trilivy™, a science-backed, coach-guided metabolic health system, points to five frequently overlooked patterns adults can recognize before noticeable weight and energy fluctuations.

Trilivy™ is designed to address the challenges of metabolic dysfunction Clients on Trilivy's Reset 5 & 1 Plan who work with a coach lose up to 10 times more weight and 17 times more fat compared to self-directed approaches* Baltimore, MD, Sept. 29, 2026 (GLOBE NEWSWIRE) -- A weight loss plateau is one of the most common reasons people abandon a structured weight loss effort altogether.

MED is shifting toward metabolic health with its 3.0 strategy, targeting broader growth, greater efficiency and a return to profitability.

Medifast (MED) reported earnings 30 days ago. What's next for the stock?

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept.

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Metabolic Health Institute, established to advance metabolic health through rigorous research and credible, evidence-based education. The institute brings Medifast's clinical research, scientific expertise, and educational resources under a single body, solidifying the company's position in the metabolic health space. It follows the July launch of Trilivy™, which replaced OPTAVIA® as the company's co.

MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing GLP-1 market focus.

Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Great Lakes Advisors LLC purchased a new position in shares of Medifast Inc (NYSE: MED) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 51,611 shares of the specialty retailer's stock, valued at approximately $548,000. Great Lakes Advisors LLC owned approximately 0.46% of